Abrams Royal Pharmacy, License #263379. The Board
and Abrams Royal Pharmacy stipulated to the facts
that, prior to February 26, 2013, licensee did not have
patient-specific prescriptions before shipping sterile
compounded products into Minnesota; licensee did
not use United States Pharmacopeia (USP) standards
when extending beyond-use dates; and licensee’s
compounding log did not include unique identifiers
of all individuals involved in the compounding process.
Abrams Royal did not admit to wrongdoing or
violation of any statutes or rules that the Board is
empowered to enforce but, to avoid the expense of
further litigation, agreed that the Board could impose
disciplinary action. Consequently, the Board accepted
the voluntary surrender of Abrams Royal’s license.
source
source
No comments:
Post a Comment